| 2026 |
Kamath, S., Sokolenko, E., Collins, K., Chan, N. S. L., Mills, N., Clark, S. R., . . . Joyce, P. (2026). IUPHAR Themed Review: The Gut Microbiome in Schizophrenia.. Pharmacological Research, 211(107561), 107561-1-107561-13.
DOI Scopus23 WoS20 Europe PMC15 |
| 2026 |
Kamath, S., Chan, N. S. L., & Joyce, P. (2026). GLP-1 agonists and the gut microbiome: A bidirectional relationship. British Journal of Clinical Pharmacology, 92(5), 1309-1325.
DOI Scopus15 WoS17 Europe PMC9 |
| 2026 |
Kamath, S., Sun, Y. -H., Wardill, H. R., & Joyce, P. (2026). Gut-brain axis targeting postbiotics for treatment of psychological and neurodegenerative disorders. Food Bioscience, 80, 108950.
DOI Scopus2 WoS2 |
| 2026 |
Collins, K., Donnellan, L., Asif, Z., Chan, N. S. L., Subramaniam, S., Kamath, S., . . . Joyce, P. (2026). The gut microbiome modulates the lipase-mediated digestion of dietary lipid emulsions. Colloids and Surfaces B: Biointerfaces, 265, 115715-1-115715-14.
DOI Scopus2 WoS2 Europe PMC1 |
| 2026 |
Khetan, R., Donnellan, L., Collins, K., Kamath, S., Ariaee, A., Rajapaksha, W., . . . Joyce, P. (2026). The gut microbiota regulates the protein corona formation, biodistribution, and cellular uptake of lipid nanoparticles. Journal of Controlled Release, 395, 114995-1-114995-15.
DOI |
| 2026 |
Collins, K., Kamath, S., Davis, R. H., Costello, S. P., Bryant, R. V., Day, A. S., & Joyce, P. (2026). Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy. Alimentary Pharmacology and Therapeutics, 19 pages.
DOI |
| 2025 |
Kamath, S., Bryant, R. V., Costello, S. P., Day, A. S., Forbes, B., Haifer, C., . . . Joyce, P. (2025). Translational strategies for oral delivery of faecal microbiota transplantation.. Gut, online(12), gutjnl-2025-335077.
DOI Scopus21 WoS21 Europe PMC10 |
| 2025 |
Kamath, S., Sokolenko, E., Clark, S. R., Cross, C. B., Scott, J., Wardill, H. R., . . . Joyce, P. (2025). Distinguishing the causative, correlative and bidirectional roles of the gut microbiota in mental health. Nature mental health, 3(10), 1137-1151.
DOI Scopus13 WoS16 |
| 2025 |
Kamath, S., & Joyce, P. (2025). A critical need for 'gut neutrality': mitigating adverse drug-microbiome interactions. Expert Opinion on Drug Metabolism and Toxicology, 21(1), 1-4.
DOI Scopus19 WoS16 Europe PMC5 |
| 2025 |
Kamath, S., Ariaee, A., Abdelhafez, A., Asif, Z., Chan, N. S. L., Collins, K., . . . Joyce, P. (2025). Microbiome-active drug delivery systems (MADDS): leveraging microbial stimuli for controlled drug release. Advanced Drug Delivery Reviews, 227(115720), 1-23.
DOI Scopus18 WoS13 Europe PMC6 |
| 2024 |
Stringer, A. M., Hargreaves, B. M., Mendes, R. A., Blijlevens, N. M. A., Bruno, J. S., Joyce, P., . . . Wardill, H. R. (2024). Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 32(8), 558-1-558-15.
DOI Scopus20 WoS19 Europe PMC11 |
| 2024 |
Meola, T. R., Kamath, S., Elz, A. S., Prestidge, C. A., Wignall, A., & Joyce, P. (2024). Contrasting the pharmacokinetic performance and gut microbiota effects of an amorphous solid dispersion and lipid nanoemulsion for a poorly water-soluble anti-psychotic. European Journal of Pharmaceutics and Biopharmaceutics, 203, 10 pages.
DOI Scopus6 WoS5 Europe PMC3 |
| 2024 |
Kamath, S., Hunter, A., Collins, K., Wignall, A., & Joyce, P. (2024). The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats. British Journal of Pharmacology, 181(22), 4531-4545.
DOI Scopus23 WoS22 Europe PMC17 |
| 2024 |
Meola, T. R., Elz, A., Wignall, A., Paxton, K., Hunter, A., Ariaee, A., . . . Joyce, P. (2024). Inulin-Lipid Core–Shell Microcapsules Target the Gut Microbiota and Mimic the Pharmaceutical Food Effect for Improved Oral Antipsychotic Delivery. Advanced Functional Materials, 34(40), 12 pages.
DOI Scopus22 WoS20 |
| 2023 |
Kamath, S., Stringer, A. M., Prestidge, C. A., & Joyce, P. (2023). Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery. Expert Opinion on Drug Delivery, 20(10), 1315-1331.
DOI Scopus45 WoS41 Europe PMC30 |
| 2023 |
Subramaniam, S., Elz, A., Wignall, A., Kamath, S., Ariaee, A., Hunter, A., . . . Joyce, P. (2023). Self-emulsifying drug delivery systems (SEDDS) disrupt the gut microbiota and trigger an intestinal inflammatory response in rats. International Journal of Pharmaceutics, 648(123614), 123614-1-123614-10.
DOI Scopus42 WoS35 Europe PMC23 |
| 2023 |
Kamath, S., Soo, B., Mill, D., Johnson, J., & Page, A. T. (2023). Who would be a pharmacist? A national representative cross-sectional survey of pharmacists and students to explore personality traits and associations with job satisfaction and career outlook. International Journal Of Pharmacy Practice, 31(3), 328-336.
DOI Scopus4 WoS4 Europe PMC1 |
| 2023 |
Subramaniam, S., Kamath, S., Ariaee, A., Prestidge, C., & Joyce, P. (2023). The impact of common pharmaceutical excipients on the gut microbiota. Expert Opinion on Drug Delivery, 20(10), 1297-1394.
DOI Scopus34 WoS33 Europe PMC25 |
